A rare condition in which inflammation causes muscle weakness and affects both sides of the body is known as polymyositis. The condition can make it difficult to climb stairs, rise from a seated ...

Belonging to the same group of autoimmune diseases, both dermatomyositis and polymyositis cause muscle inflammation and weakness. But dermatomyositis also affects your skin and is more likely to ...

Polymyositis is a rare inflammatory disease that leads to muscle weakness, swelling tenderness, and tissue damage. It is part of a larger group of diseases called myositis. It is called ...

According to the researchers, the incidence rate for opportunistic infections was highest among patients with polymyositis or dermatomyositis, with 61.3 per 1,000 person-years, (95% CI, 56.6-66.2).

Las Vegas, USAPolymyositis Pipeline to Progress with New and Emerging Drugs for Treatment, Analyzes , Dec. 08, 2021 (GLOBE NEWSWIRE) -- DelveInsight’s ‘Polymyositis Pipeline Insight 2021 ...

This page lists all known medications that could potentially lead to 'Polymyositis' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Q: Which doctor should I consult for polymyositis? A: A neurologist or rheumatologist must be consulted first and additional expertise may be required from a pulmonologist, physiotherapist and ...

Polymyositis (PM) and dermatomyositis (DM) may involve the striated muscle of the esophagus, leading to abnormal swallowing that in turn can lead to malnutrition and/or aspiration. Esophageal ...

PF1801 is a novel long-acting glucagon-like peptide-1 receptor agonist. The Food and Drug Administration (FDA) has granted Orphan Drug designation to PF1801 for the treatment of polymyositis.